Memphasys Ltd (AU:MEM)
ASX:MEM
Holding AU:MEM?
Track your performance easily

Memphasys Ltd (MEM) Share Price & Analysis

5 Followers

MEM Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

20.92%0.00%0.00%79.08%
20.92%
Insiders
0.00% Other Institutional Investors
79.08% Public Companies and
Individual Investors

MEM FAQ

What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
    What is Memphasys Ltd’s market cap?
    Currently, no data Available
    When is Memphasys Ltd’s upcoming earnings report date?
    Memphasys Ltd’s upcoming earnings report date is Feb 21, 2025 which is in 154 days.
      How were Memphasys Ltd’s earnings last quarter?
      Memphasys Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
        Is Memphasys Ltd overvalued?
        According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Memphasys Ltd pay dividends?
          Memphasys Ltd does not currently pay dividends.
          What is Memphasys Ltd’s EPS estimate?
          Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Memphasys Ltd have?
          Memphasys Ltd has 1,445,248,200 shares outstanding.
            What happened to Memphasys Ltd’s price movement after its last earnings report?
            Memphasys Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Memphasys Ltd?
              Currently, no hedge funds are holding shares in AU:MEM
              ---

              Memphasys Ltd Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -62.46%
              Trailing 12-Months
              Asset Growth
              -15.26%
              Trailing 12-Months

              Company Description

              Memphasys Ltd

              Memphasys Ltd operates as a bio-separations company in Australia. It is engaged in developing and commercializing separation techniques based on the company's proprietary membrane technology. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Avecho Biotechnology Limited
              Race Oncology Ltd.
              LBT Innovations Limited
              PainChek Ltd
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis